1  and is a tumor suppressor in esophageal and nasopharyngeal cancer.

2 y versus radiotherapy alone in patients with nasopharyngeal cancers.

3 15 men with upper airway cancer (including 1 nasopharyngeal cancer), 92 men with leukemia, and 45 men

4 isease as well as EBV-positive lymphomas and nasopharyngeal cancer, although a recent study also show

5    Respiratory tract cancers, including both nasopharyngeal cancer and lung cancer, are strongly asso

6  sequence were similar to those described in nasopharyngeal cancer and lymphoma tissues, including tw

7 ved in the development and/or progression of nasopharyngeal cancer and suggest that RB2/p130 could be

8                                    Childhood nasopharyngeal cancers are often diagnosed at an advance

9 posure-response relation with mortality from nasopharyngeal cancer (based on small numbers) but not f

10 ns on activity against the growth of a human nasopharyngeal cancer cell line KB and its P-gp 170 over

11  well as survival for patients with advanced nasopharyngeal cancer compared with standard RT alone.

12 technique for treatment of locally recurrent nasopharyngeal cancer (lrNPC).

13                           Relative risks for nasopharyngeal cancer (nine deaths) increased with avera

14 h a nonrandomized cohort of 51 patients with nasopharyngeal cancer treated with 70-Gy standard fracti

15 adiotherapy alone for patients with advanced nasopharyngeal cancers with respect to PFS and overall s